Friedl-Naderer Johanna 4
4 · Dyne Therapeutics, Inc. · Filed Dec 6, 2024
Insider Transaction Report
Form 4
Friedl-Naderer Johanna
Chief Commercial Officer
Transactions
- Award
Stock option (right to buy)
2024-12-04+60,300→ 60,300 totalExercise: $29.44Exp: 2034-12-03→ Common Stock (60,300 underlying) - Award
Common Stock
2024-12-04+37,800→ 96,200 total
Footnotes (3)
- [F1]Consists of shares of Common Stock issuable under 37,800 restricted stock units ("RSUs"). Each RSU represents the right to receive one share of Common Stock upon vesting. These RSUs are scheduled to vest in equal quarterly installments over four years with the first installment vesting on March 4, 2025.
- [F2]Includes 96,200 unvested RSUs.
- [F3]This option was granted on December 4, 2024. The shares underlying the option are scheduled to vest over four years in equal monthly installments through December 4, 2028.